Will SPAR be useful in the usual patients with scleroderma?
Ann Rheum Dis
.
2019 Nov;78(11):e125.
doi: 10.1136/annrheumdis-2018-214256.
Epub 2018 Sep 7.
Authors
Arghya Chattopadhyay
1
,
Varun Dhir
2
,
Shefali Sharma
1
,
Aman Sharma
1
,
Sanjay Jain
1
Affiliations
1
Internal Medicine, Clinical Immunology and Rheumatology Services, Chandigarh, India.
2
Internal Medicine, Clinical Immunology and Rheumatology Services, Chandigarh, India
[email protected]
.
PMID:
30194274
DOI:
10.1136/annrheumdis-2018-214256
No abstract available
Keywords:
arthritis; disease activity; treatment.
Publication types
Letter
Comment
MeSH terms
Disease Progression
Humans
Lung Diseases, Interstitial*
Scleroderma, Localized*
Scleroderma, Systemic*